
Flagship Biosciences is a CLIA-Certified and CAP-Accredited technology-driven spatial biology and biomarker services company, founded in 2009. They specialize in drug development and diagnostics, utilizing AI-powered analysis and expert consultation. The company delivers accurate, insightful data by eliminating variability in traditional methods and uncovering new biological insights. Their services include spatial biology (image analysis, IHC, mIF, digital spatial profiling, ISH), genomics (RNASeq, WES, WGS, NGS panels, gene expression analysis, qPCR/Sanger sequencing), and histopathology. They also focus on companion diagnostics, offering biomarker development and regulatory support. Flagship Biosciences aims to improve patient outcomes by providing partners with responsive, expert-driven service that combines AI-powered biomarker analysis with personalized scientific consultation for actionable insights.

Flagship Biosciences is a CLIA-Certified and CAP-Accredited technology-driven spatial biology and biomarker services company, founded in 2009. They specialize in drug development and diagnostics, utilizing AI-powered analysis and expert consultation. The company delivers accurate, insightful data by eliminating variability in traditional methods and uncovering new biological insights. Their services include spatial biology (image analysis, IHC, mIF, digital spatial profiling, ISH), genomics (RNASeq, WES, WGS, NGS panels, gene expression analysis, qPCR/Sanger sequencing), and histopathology. They also focus on companion diagnostics, offering biomarker development and regulatory support. Flagship Biosciences aims to improve patient outcomes by providing partners with responsive, expert-driven service that combines AI-powered biomarker analysis with personalized scientific consultation for actionable insights.